Please wait while the formulary information is being retrieved.
Drug overview for NOVAREL (chorionic gonadotropin, human):
Generic name: CHORIONIC GONADOTROPIN, HUMAN (KOR-ee-ON-ik goe-NAD-oh-TROE-pin)
Drug class: Human Chorionic Gonadotropin (hCG)
Therapeutic class: Endocrine
Chorionic gonadotropin (CG) is a gonad-stimulating polypeptide hormone secreted by the placenta, that is obtained from urine of pregnant women.
No enhanced Uses information available for this drug.
Generic name: CHORIONIC GONADOTROPIN, HUMAN (KOR-ee-ON-ik goe-NAD-oh-TROE-pin)
Drug class: Human Chorionic Gonadotropin (hCG)
Therapeutic class: Endocrine
Chorionic gonadotropin (CG) is a gonad-stimulating polypeptide hormone secreted by the placenta, that is obtained from urine of pregnant women.
No enhanced Uses information available for this drug.
DRUG IMAGES
NOVAREL 5,000 UNIT VIAL
The following indications for NOVAREL (chorionic gonadotropin, human) have been approved by the FDA:
Indications:
Cryptorchidism
Hypogonadotropic hypogonadism
Infertility associated with anovulation
Professional Synonyms:
Infertility associated with ovulation failure
Undescended testis
Indications:
Cryptorchidism
Hypogonadotropic hypogonadism
Infertility associated with anovulation
Professional Synonyms:
Infertility associated with ovulation failure
Undescended testis
The following dosing information is available for NOVAREL (chorionic gonadotropin, human):
Dosage of chorionic gonadotropin is expressed in terms of USP units. Dosage regimens of chorionic gonadotropin vary widely, and dosage must be carefully individualized based on the condition being treated, age and weight of the patient, and the clinician's judgment.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for NOVAREL (chorionic gonadotropin, human):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for NOVAREL (chorionic gonadotropin, human):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 5 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Estrogen-dependent neoplasm |
| Malignant tumor of testis |
| Pituitary neoplasm |
| Precocious puberty |
| Prostatic carcinoma |
There are 2 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Ovarian hyperstimulation syndrome |
| Thromboembolic disorder |
There are 2 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Edema |
| Torsion of ovary |
The following adverse reaction information is available for NOVAREL (chorionic gonadotropin, human):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 8 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Ovarian enlargement Torsion of ovary |
Precocious puberty |
| Rare/Very Rare |
|---|
|
Acute arterial thromboembolism Anaphylaxis Hypersensitivity drug reaction Ovarian hyperstimulation syndrome Ruptured ovarian cyst |
There are 8 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Edema |
Depression Fatigue Gynecomastia Headache disorder Injection site sequelae Irritability Nervousness |
| Rare/Very Rare |
|---|
| None. |
The following precautions are available for NOVAREL (chorionic gonadotropin, human):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
Chorionic gonadotropin (CG) may cause fetal toxicity when administered to a pregnant woman. (See Cautions: Pregnancy, in Menotropins 68:18.)
Since it is not known whether chorionic gonadotropin is distributed into human milk, the drug should be used with caution in nursing women.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for NOVAREL (chorionic gonadotropin, human):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for NOVAREL (chorionic gonadotropin, human)'s list of indications:
| Cryptorchidism | |
| Q53 | Undescended and ectopic testicle |
| Q53.0 | Ectopic testis |
| Q53.00 | Ectopic testis, unspecified |
| Q53.01 | Ectopic testis, unilateral |
| Q53.02 | Ectopic testes, bilateral |
| Q53.1 | Undescended testicle, unilateral |
| Q53.10 | Unspecified undescended testicle, unilateral |
| Q53.11 | Abdominal testis, unilateral |
| Q53.111 | Unilateral intraabdominal testis |
| Q53.112 | Unilateral inguinal testis |
| Q53.12 | Ectopic perineal testis, unilateral |
| Q53.13 | Unilateral high scrotal testis |
| Q53.2 | Undescended testicle, bilateral |
| Q53.20 | Undescended testicle, unspecified, bilateral |
| Q53.21 | Abdominal testis, bilateral |
| Q53.211 | Bilateral intraabdominal testes |
| Q53.212 | Bilateral inguinal testes |
| Q53.22 | Ectopic perineal testis, bilateral |
| Q53.23 | Bilateral high scrotal testes |
| Q53.9 | Undescended testicle, unspecified |
| R39.83 | Unilateral non-palpable testicle |
| R39.84 | Bilateral non-palpable testicles |
| Hypogonadotropic hypogonadism | |
| E23.0 | Hypopituitarism |
| Infertility associated with anovulation | |
| N97.0 | Female infertility associated with anovulation |
Formulary Reference Tool